The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases N Chalasani, Z Younossi, JE Lavine, M Charlton, K Cusi, M Rinella, ... Hepatology 67 (1), 328-357, 2018 | 6776 | 2018 |
Mechanisms of NAFLD development and therapeutic strategies SL Friedman, BA Neuschwander-Tetri, M Rinella, AJ Sanyal Nature medicine 24 (7), 908-922, 2018 | 3370 | 2018 |
MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease M Eslam, AJ Sanyal, J George, A Sanyal, B Neuschwander-Tetri, ... Gastroenterology 158 (7), 1999-2014. e1, 2020 | 2746 | 2020 |
Nonalcoholic fatty liver disease: a systematic review ME Rinella Jama 313 (22), 2263-2273, 2015 | 2663 | 2015 |
A multi-society Delphi consensus statement on new fatty liver disease nomenclature ME Rinella, JV Lazarus, V Ratziu, SM Francque, AJ Sanyal, F Kanwal, ... Annals of Hepatology, 101133, 2023 | 1886 | 2023 |
Non-alcoholic fatty liver disease EE Powell, VWS Wong, M Rinella The Lancet 397 (10290), 2212-2224, 2021 | 1700 | 2021 |
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1123 | 2019 |
Nonalcoholic fatty liver disease 2020: the state of the disease TG Cotter, M Rinella Gastroenterology 158 (7), 1851-1864, 2020 | 1015 | 2020 |
Nonalcoholic fatty liver disease EM Brunt, VWS Wong, V Nobili, CP Day, S Sookoian, JJ Maher, ... Nature reviews Disease primers 1 (1), 1-22, 2015 | 863 | 2015 |
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease ME Rinella, BA Neuschwander-Tetri, MS Siddiqui, MF Abdelmalek, ... Hepatology 77 (5), 1797-1835, 2023 | 790 | 2023 |
American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and … K Cusi, S Isaacs, D Barb, R Basu, S Caprio, WT Garvey, S Kashyap, ... Endocrine Practice 28 (5), 528-562, 2022 | 576 | 2022 |
The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance ME Rinella, RM Green Journal of hepatology 40 (1), 47-51, 2004 | 531 | 2004 |
Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet ME Rinella, MS Elias, RR Smolak, T Fu, J Borensztajn, RM Green Journal of lipid research 49 (5), 1068-1076, 2008 | 528 | 2008 |
Advancing the global public health agenda for NAFLD: a consensus statement JV Lazarus, HE Mark, QM Anstee, JP Arab, RL Batterham, L Castera, ... Nature Reviews Gastroenterology & Hepatology 19 (1), 60-78, 2022 | 499 | 2022 |
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis ZM Younossi, R Loomba, QM Anstee, ME Rinella, E Bugianesi, ... Hepatology 68 (1), 349-360, 2018 | 441 | 2018 |
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial SA Harrison, ME Rinella, MF Abdelmalek, JF Trotter, AH Paredes, ... The Lancet 391 (10126), 1174-1185, 2018 | 436 | 2018 |
Management of NAFLD: a stage-based approach ME Rinella, AJ Sanyal Nature reviews Gastroenterology & hepatology 13 (4), 196-205, 2016 | 423 | 2016 |
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis ZM Younossi, R Loomba, ME Rinella, E Bugianesi, G Marchesini, ... Hepatology 68 (1), 361-371, 2018 | 393 | 2018 |
From NAFLD to MAFLD: implications of a premature change in terminology ZM Younossi, ME Rinella, AJ Sanyal, SA Harrison, EM Brunt, Z Goodman, ... Hepatology 73 (3), 1194-1198, 2021 | 369 | 2021 |
Body mass index as a predictor of hepatic steatosis in living liver donors ME Rinella, E Alonso, S Rao, P Whitington, J Fryer, M Abecassis, ... Liver Transplantation 7 (5), 409-414, 2001 | 350 | 2001 |